tiprankstipranks
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market

Compare Contineum Therapeutics, Inc. Class A (CTNM) vs. Competitors

212 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Contineum Therapeutics, Inc. Class A
$13.44
$520.89M
-5.28
98.23%
5 Buy
1 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$3.02
$28.33M
-1.75
-80.26%
4 Buy
3 Hold
0 Sell
Moderate Buy
Capricor Therapeutics
$32.11
$1.85B
-12.77
229.67%
8 Buy
0 Hold
0 Sell
Strong Buy
Alpha Tau Medical Ltd
$6.84
$609.03M
-9.36
168.22%
2 Buy
1 Hold
0 Sell
Moderate Buy
Immuneering
$5.45
$352.36M
-5.17
249.36%
5 Buy
0 Hold
0 Sell
Strong Buy
enGene Holdings
$6.69
$448.16M
-5.39
50.68%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CTNM
Contineum Therapeutics, Inc. Class A
13.44
8.07
150.28%
TVRD
Tvardi Therapeutics
3.02
-11.23
-78.81%
CAPR
Capricor Therapeutics
32.11
22.93
249.78%
DRTS
Alpha Tau Medical Ltd
6.92
4.47
182.45%
IMRX
Immuneering
5.45
4.10
303.70%
ENGN
enGene Holdings
6.69
2.01
42.95%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts